Lobbying disclosure: Alphabet, AT&T, ExxonMobil
Separate CEO/Chair: AbbVie, Johnson & Johnson (withdrawn after company agreed to compromise), Pfizer
Report on obesity: Dr. Pepper Snapple
Report on the degree to which risks related to public concern over drug-pricing strategies are integrated into compensation incentive policies: Amgen (SEC denied company's no-action request)
Report on policy of not doing business with governments complicit in genocide and/or crimes against humanity: Chevron (SEC considering company's no-action request)
At this time, none of these AGMs have taken place so outcomes are unknown.